Detalhe da pesquisa
1.
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
Lancet
; 2024 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38705160
2.
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy.
Br J Haematol
; 2024 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38613141
3.
Novel pyrrolidine-aminophenyl-1,4-naphthoquinones: structure-related mechanisms of leukemia cell death.
Mol Cell Biochem
; 478(2): 393-406, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-35836027
4.
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era.
Blood
; 135(22): 1929-1945, 2020 05 28.
Artigo
Inglês
| MEDLINE | ID: mdl-32187362
5.
Deferasirox induces cyclin D1 degradation and apoptosis in mantle cell lymphoma in a reactive oxygen species- and GSK3ß-dependent mechanism.
Br J Haematol
; 192(4): 747-760, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33521925
6.
Non-Coding RNAs in Normal B-Cell Development and in Mantle Cell Lymphoma: From Molecular Mechanism to Biomarker and Therapeutic Agent Potential.
Int J Mol Sci
; 22(17)2021 Aug 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34502399
7.
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Lancet
; 394(10216): 2271-2281, 2019 12 21.
Artigo
Inglês
| MEDLINE | ID: mdl-31868632
8.
Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspects.
Br J Haematol
; 181(3): 306-319, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29359797
9.
Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
J Nanobiotechnology
; 16(1): 34, 2018 Mar 30.
Artigo
Inglês
| MEDLINE | ID: mdl-29602308
10.
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients.
Br J Haematol
; 178(5): 709-718, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28589704
11.
Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growth.
Br J Haematol
; 178(6): 896-905, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28677826
12.
Bendamustine-associated infections-systematic review and meta-analysis of randomized controlled trials.
Hematol Oncol
; 35(4): 424-431, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27734524
13.
18F-FDG-PET/CT Pulmonary Infiltrates in Non-Hodgkin Lymphoma Patients Treated with Combined Immunochemotherapy: Incidence and Clinical Characteristics.
Isr Med Assoc J
; 19(6): 372-377, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28647936
14.
Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma.
Blood
; 123(26): 4136-42, 2014 Jun 26.
Artigo
Inglês
| MEDLINE | ID: mdl-24833354
15.
Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor.
Hematol Oncol
; 34(4): 184-192, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26052918
16.
High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia--is more better or more of the same?
Hematol Oncol
; 34(1): 28-35, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25689584
17.
CHOP-like-14 compared to CHOP-like-21 for patients with aggressive lymphoma--a meta-analysis of randomized controlled trials.
Acta Oncol
; 55(1): 77-84, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-25997705
18.
High-Intensity Induction Chemotherapy Is Feasible for Elderly Patients with Acute Myeloid Leukemia.
Acta Haematol
; 135(1): 55-64, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26443995
19.
Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study.
Biol Blood Marrow Transplant
; 21(10): 1770-5, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26033282
20.
Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up.
Br J Haematol
; 171(3): 344-54, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26153365